How Your Company Can Support Cycle for Survival
Unite with your colleagues
When you and your coworkers join Cycle for Survival, you’ll work together as a team to support rare cancer research at MSK. You can even bring together fellow employees from across the country.
We can each do our part to fund rare cancer research. It means the world to me to be part of a company like Standard Industries that supports these efforts.
–Dorit C., Standard Industries
See how companies support us
Recruit coworkers to beat rare cancers
The more people you recruit, the more funds you can raise
Got teams in multiple offices?
Join together to support rare cancer research
Corporate sponsors
Become a corporate sponsor
The impact of Cycle for Survival funds
Cycle for Survival funds have supported the development of novel immunotherapies, an investigational pancreatic cancer vaccine, a new brain tumor treatment, and more. 100% of every dollar raised supports rare cancer research at MSK, where groundbreaking discoveries are making a real difference for people around the world.
Treating a deadly cancer
An investigational personalized mRNA vaccine prevented the recurrence of pancreatic cancer in some patients. With support from Cycle for Survival, researchers continue to assess vaccines to treat people with rare cancers.
Learn moreSlowing brain tumor growth
Foundational research funded in part by Cycle for Survival led to the first novel treatment for early-stage glioma in more than 20 years. The oral drug vorasidenib significantly slowed glioma growth in some patients.
Read about it